Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM
Activity Overview
Episode publication activity over the past year
Episodes
Wrap Up
19 Nov 2024
Contributed by Lukas
Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
19 Nov 2024
Contributed by Lukas
Author: Howard, JF, et al.Overview Provided by Nicolas Silvestri, MD
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
19 Nov 2024
Contributed by Lukas
Author: Strober J, et al.Overview Provided by Nicolas Silvestri, MD
Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results
19 Nov 2024
Contributed by Lukas
Author: Nicolle M, et al.Overview Provided by Nicolas Silvestri, MD
Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT
19 Nov 2024
Contributed by Lukas
Author: Habib AA, et alOverview Provided by Nicolas Silvestri, MD
Introduction
19 Nov 2024
Contributed by Lukas